Pliant Therapeutics, Inc.
PLRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001746473
No open-market purchases or sales by Pliant Therapeutics, Inc. insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $54.8M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Pliant Therapeutics, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 110 | 2 | 125 | +17 |
| Shares | 45.4M | 1.01K | 44.7M | −682.4K (−1.5%) |
| Value | $948.1M | $21.2K | $864.1M | −$84.0M (−8.9%) |
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (37)
Institutions that held Pliant Therapeutics, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
Sold out (20)
Institutions that held Pliant Therapeutics, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Invesco Ltd. | 272,667 | $5.70M |
| Atika Capital Management LLC | 195,000 | $4.07M |
| Walleye Capital LLC | 152,741 | $3.19M |
| EAM Investors, LLC | 109,220 | $2.28M |
| EAM Global Investors LLC | 76,076 | $1.59M |
| HarbourVest Partners LLC | 64,826 | $1.35M |
| Ergoteles LLC | 29,928 | $625.0K |
| Soleus Capital Management, L.P. | 21,200 | $443.0K |
| Standard Life Aberdeen plc | 19,724 | $412.0K |
| SEI Investments Co | 19,653 | $411.0K |
| Occudo Quantitative Strategies LP | 13,438 | $281.0K |
| Walleye Trading LLC | 11,280 | $236.0K |
| HRT Financial LP | 11,339 | $236.0K |
| Schonfeld Strategic Advisors LLC | 10,000 | $209.0K |
| Simplex Trading, LLC | 3,461 | $72.0K |
| Dark Forest Capital Management LP | 1,988 | $42.0K |
| Global Trust Asset Management, LLC | 291 | $6.00K |
| Massmutual Trust Co FSB | 90 | $2.00K |
| Allworth Financial LP | 39 | $1.00K |
| Quadrant Capital Group LLC | 51 | $1.00K |
Not filed for Q4 2022 yet (2)
Institutions that held Pliant Therapeutics, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| FourThought Financial, LLC | 809 | $17.0K |
| American Portfolios Advisors | 200 | $4.18K |